Seismic raises $121M to enter immunology space spotlighted by argenx, Immunovant and others

Seismic Therapeutic has raised $121 million in a Series B, about 20% larger than it had originally sought, to enter the clinic with two biologics created using its machine learning tools, it said Monday morning.

The financing will help the biotech speed forward at the intersection of two burgeoning fields…
Click here to view original post